NASDAQ:PMTI - Palomar Medical Technologies Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous Close$13.41
Today's RangeN/A
52-Week Range$7.06 - $13.97
VolumeN/A
Average Volume128,366 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Palomar Medical Technologies, Inc. (Palomar) is a researcher and developer of aesthetic light-based systems for hair removal and other cosmetic procedures, including both lasers and high powered lamps. The Company offers a range of products based on technologies that include, but are not limited to: hair removal; body sculpting, including laser-assisted liposuction; removal of vascular lesions, such as rosacea, spider veins, port wine stains and hemangiomas; wrinkle reduction; removal of leg veins; removal of benign pigmented lesions, such as age and sun spots, freckles and melasma; tattoo removal; acne treatment; skin resurfacing, pseudofolliculitis barbae (PFB) treatment; treatment of red pigmentation in hypertrophic and keloid scars; treatment of verrucae, skin tags and seborrheic keratosis; skin tightening through soft tissue coagulation; scars, and other skin treatments. In June 2013, Cynosure Inc announced the completion of its acquisition of Palomar Medical Technologies Inc.

Receive PMTI News and Ratings via Email

Sign-up to receive the latest news and ratings for PMTI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryHealth Care Equipment
SectorN/A
Current SymbolNASDAQ:PMTI
CUSIP69752930
Phone+1-781-9932300

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Palomar Medical Technologies (NASDAQ:PMTI) Frequently Asked Questions

What is Palomar Medical Technologies' stock symbol?

Palomar Medical Technologies trades on the NASDAQ under the ticker symbol "PMTI."

Has Palomar Medical Technologies been receiving favorable news coverage?

News articles about PMTI stock have been trending somewhat positive this week, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Palomar Medical Technologies earned a media sentiment score of 1.7 on InfoTrie's scale. They also assigned news headlines about the healthcare company a news buzz of 5.0 out of 10, indicating that recent press coverage is somewhat likely to have an effect on the stock's share price in the immediate future.

Who are Palomar Medical Technologies' key executives?

Palomar Medical Technologies' management team includes the folowing people:
  • Joseph P. Caruso, Chairman of the Board, President, Chief Executive Officer (Age 54)
  • Paul S. Weiner, Chief Financial Officer, Treasurer (Age 53)
  • Louis P. Valente, Director (Age 81)
  • Jeanne Cohane, Independent Director (Age 65)
  • Damian N. Dell'Anno, Independent Director
  • Nicholas P. Economou Ph.D., Independent Director (Age 63)
  • James G. Martin Ph.D., Independent Director (Age 78)

How do I buy shares of Palomar Medical Technologies?

Shares of PMTI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Palomar Medical Technologies' official website?

The official website for Palomar Medical Technologies is http://www.palomarmedical.com/.

How can I contact Palomar Medical Technologies?

Palomar Medical Technologies' mailing address is 15 Network Drive, BURLINGTON, MA 1803, United States. The healthcare company can be reached via phone at +1-781-9932300.


MarketBeat Community Rating for Palomar Medical Technologies (NASDAQ PMTI)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  69 (Vote Outperform)
Underperform Votes:  94 (Vote Underperform)
Total Votes:  163
MarketBeat's community ratings are surveys of what our community members think about Palomar Medical Technologies and other stocks. Vote "Outperform" if you believe PMTI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PMTI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/21/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel